Minerva Neurosciences Files 8-K
Ticker: NERV · Form: 8-K · Filed: Sep 16, 2024 · CIK: 1598646
Sentiment: neutral
Topics: 8-K, regulatory-filing, other-event
Related Tickers: MINV
TL;DR
MINV filed an 8-K, something happened on 9/14, details TBD.
AI Summary
Minerva Neurosciences, Inc. filed an 8-K on September 16, 2024, reporting an "Other Event" as of September 14, 2024. The filing does not contain specific details about the event itself, only the standard reporting information for a Form 8-K.
Why It Matters
This filing indicates a material event has occurred for Minerva Neurosciences, Inc. that requires public disclosure, though the specific nature of the event is not detailed in this initial report.
Risk Assessment
Risk Level: medium — The filing indicates a material event occurred, but the lack of detail creates uncertainty about its impact.
Key Numbers
- 000-36517 — SEC File Number (Registrant's SEC file number)
- 26-0784194 — IRS Employer ID Number (Registrant's IRS Employer Identification Number)
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Registrant
- September 14, 2024 (date) — Date of earliest event reported
- September 16, 2024 (date) — Date of report
- 0001193125-24-219590 (filing_id) — Accession Number
FAQ
What specific event is Minerva Neurosciences, Inc. reporting in this 8-K filing?
The filing is an 8-K reporting an 'Other Event' as of September 14, 2024, but the specific details of the event are not disclosed in the provided text.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on September 16, 2024.
What is the principal executive office address for Minerva Neurosciences, Inc.?
The address of Minerva Neurosciences, Inc.'s principal executive offices is 1500 District Avenue, Burlington, MA 01803.
What is the company's telephone number?
The company's telephone number is (617) 600-7373.
Under which section of the Securities Exchange Act is this report filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 612 words · 2 min read · ~2 pages · Grade level 14.8 · Accepted 2024-09-16 16:05:53
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NERV The Nasdaq
Filing Documents
- d896018d8k.htm (8-K) — 23KB
- 0001193125-24-219590.txt ( ) — 139KB
- nerv-20240914.xsd (EX-101.SCH) — 3KB
- nerv-20240914_lab.xml (EX-101.LAB) — 17KB
- nerv-20240914_pre.xml (EX-101.PRE) — 11KB
- d896018d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MINERVA NEUROSCIENCES, INC. Dated: September 16, 2024 By: /s/ Frederick Ahlholm Name: Frederick Ahlholm Title: Chief Financial Officer